Discovery of a Potent, Selective, and Brain-Penetrant Small Molecule that Activates the Orphan Receptor GPR88 and Reduces Alcohol Intake

Journal of Medicinal Chemistry
Chunyang JinRangan Maitra

Abstract

The orphan G-protein-coupled receptor GPR88 is highly expressed in the striatum. Studies using GPR88 knockout mice have suggested that the receptor is implicated in alcohol seeking and drinking behaviors. To date, the biological effects of GPR88 activation are still unknown due to the lack of a potent and selective agonist appropriate for in vivo investigation. In this study, we report the discovery of the first potent, selective, and brain-penetrant GPR88 agonist RTI-13951-33 (6). RTI-13951-33 exhibited an EC50 of 25 nM in an in vitro cAMP functional assay and had no significant off-target activity at 38 GPCRs, ion channels, and neurotransmitter transporters that were tested. RTI-13951-33 displayed enhanced aqueous solubility compared to (1 R,2 R)-2-PCCA (2) and had favorable pharmacokinetic properties for behavioral assessment. Finally, RTI-13951-33 significantly reduced alcohol self-administration and alcohol intake in a dose-dependent manner without effects on locomotion and sucrose self-administration in rats when administered intraperitoneally.

References

Feb 1, 2000·Drug Discovery Today·D E Clark, S D Pickett
Mar 21, 2006·Pharmacology & Therapeutics·Markus Heilig, Mark Egli
Dec 22, 2006·Journal of Medicinal Chemistry·Stephen A Hitchcock, Lewis D Pennington
Apr 5, 2007·The Journal of Pharmacology and Experimental Therapeutics·Scott G SummerfieldPhil Jeffrey
Nov 27, 2009·Substance Abuse Treatment, Prevention, and Policy·Montarat ThavorncharoensapUsa Chaikledkaew
Aug 31, 2011·Bioorganic & Medicinal Chemistry Letters·Alan FulpRangan Maitra
Oct 21, 2011·Nature Reviews. Neuroscience·Markus HeiligCharles P O'Brien
Mar 1, 2012·Journal of Medicinal Chemistry·Alan FulpRangan Maitra
Jan 1, 2011·International Journal of Psychiatry in Medicine·Peter M MillerScott H Stewart
Oct 16, 2012·Nature Neuroscience·Albert QuintanaRichard D Palmiter
Nov 20, 2012·Neuropharmacology·Changhai CuiMark V Wilcox
Feb 7, 2015·Psychopharmacology·Patrick A RandallJoyce Besheer
Mar 11, 2015·Bioorganic & Medicinal Chemistry Letters·Yingzhi BiJohn E Macor
Oct 16, 2015·Revista da Associação Médica Brasileira·João Victor Vezali CostardiSônia Valéria Pinheiro Malheiros
Aug 30, 2016·ENeuro·Aura Carole MeirsmanBrigitte Lina Kieffer
Mar 28, 2017·Neuropharmacology·David M Lovinger, Veronica A Alvarez
Mar 30, 2017·Pharmacology, Biochemistry, and Behavior·Patrick A RandallJoyce Besheer
Nov 8, 2017·Brain Structure & Function·Aliza T EhrlichBrigitte L Kieffer
Dec 1, 2017·Neuropharmacology·Anel A JaramilloJoyce Besheer
Mar 28, 2018·Biological Psychiatry·Sami Ben HamidaBrigitte Lina Kieffer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.